Skip to main content
. 2020 Jan 21;12(3):191–195. doi: 10.3892/mco.2020.1981

Table III.

Median survival based on operative approach and CTC status.

    CTC detected CTC not detected
Surgery Total Total (%) Survival (months) Total (%) Survival (months)
VATS 7 6(86)a 54b 1(14) 23b
Open 26 20(77)a 38b 6(23) 37b

aNo significant difference was observed in the proportion of patients in the VATS or open group who were positive for CTCs, P=0.63.

bSurvival in the patients undergoing a thoracoscopic approach was improved but not significantly, P=0.43. CTC, circulating tumour cells.